Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Jen Liu

Showing results (51-60 of 400) with videos related to

Pageof 40
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 31, 2016
Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved responseChun-Ming Hong, Chun-Jen Liu, Shiou-Hwei Yeh, et al.
Gut|February 24, 2010
Metabolic syndrome on top of chronic hepatitis B: the more, the worse?Li-Chun Chang, Chen-Shuan Chung, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 19, 2025
IgG4-associated autoimmune hepatitis in a 70-year-old woman with progressive liver failure: First case report in TaiwanChun-Hsun Liao, Hsu-Hua Tseng, Tzu-Chan Hong, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 2, 2026
Physicians, case managers, and HCV patients recommend a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus infection with DAA therapiesChun-Jen Liu, Hsin-Jung Lin, David Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2008
Viral hepatocarcinogenesis: from infection to cancerAlexander Tan, Shiou-Hwie Yeh, Chun-Jen Liu, et al.
Hepatology International|November 11, 2025
The combination of ropeginterferon alfa-2b with anti-PD1 blockage in adjuvant therapy in HBV-related HCCAlbert Qin, Ming-Chih Ho, Chan-Yen Tsai, et al.
Hepatology International|April 5, 2025
Sequential combination with ropeginterferon alfa-2b and anti-PD-1 treatment as adjuvant therapy in HBV-related HCC: a phase 1 dose escalation trialAlbert Qin, Ming-Chih Ho, Chan-Yen Tsai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 20, 2015
Perspectives on dual hepatitis B and C infection in TaiwanChun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, et al.
Journal of Medical Virology|February 26, 2004
Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitisChun-Jen Liu, Jia-Horng Kao, Ming-Yang Lai, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2007
Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patientsChia-Chi Wang, Chun-Jen Liu, Ming-Yang Lai, et al.
Pageof 40

Showing results (51-60 of 400) with videos related to

Sort By:
Pageof 40
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 31, 2016
Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved responseChun-Ming Hong, Chun-Jen Liu, Shiou-Hwei Yeh, et al.
Gut|February 24, 2010
Metabolic syndrome on top of chronic hepatitis B: the more, the worse?Li-Chun Chang, Chen-Shuan Chung, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 19, 2025
IgG4-associated autoimmune hepatitis in a 70-year-old woman with progressive liver failure: First case report in TaiwanChun-Hsun Liao, Hsu-Hua Tseng, Tzu-Chan Hong, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 2, 2026
Physicians, case managers, and HCV patients recommend a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus infection with DAA therapiesChun-Jen Liu, Hsin-Jung Lin, David Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2008
Viral hepatocarcinogenesis: from infection to cancerAlexander Tan, Shiou-Hwie Yeh, Chun-Jen Liu, et al.
Hepatology International|November 11, 2025
The combination of ropeginterferon alfa-2b with anti-PD1 blockage in adjuvant therapy in HBV-related HCCAlbert Qin, Ming-Chih Ho, Chan-Yen Tsai, et al.
Hepatology International|April 5, 2025
Sequential combination with ropeginterferon alfa-2b and anti-PD-1 treatment as adjuvant therapy in HBV-related HCC: a phase 1 dose escalation trialAlbert Qin, Ming-Chih Ho, Chan-Yen Tsai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 20, 2015
Perspectives on dual hepatitis B and C infection in TaiwanChun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, et al.
Journal of Medical Virology|February 26, 2004
Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitisChun-Jen Liu, Jia-Horng Kao, Ming-Yang Lai, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2007
Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patientsChia-Chi Wang, Chun-Jen Liu, Ming-Yang Lai, et al.
Pageof 40